Study identifies 21 existing drugs that could treat Covid-19

As remdesivir and dexamethasone made headlines in the past months as drugs that could potentially prevent many Covid-19-related deaths, a team led by Sumit Chanda, a professor at Sanford Burnham Prebys Medical Discovery Institute, have identified 21 existing drugs that could halt replication of SARS-CoV-2.

The scientists analysed a large number of existing medications to find out which ones may block the replication of SARS-CoV-2.  From this collection, 21 drugs were found to be effective in blocking the replication of the novel coronavirus in dosages that have already been deemed safe for use in patients.

Four of these medications are also known to work well together with remdesivir, which is currently a standard treatment for Covid-19.